Galina Glazko
Concepts (282)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Computational Biology | 16 | 2025 | 209 | 3.280 |
Why?
| | Gene Expression Profiling | 16 | 2025 | 1112 | 2.360 |
Why?
| | Databases, Genetic | 9 | 2025 | 82 | 1.580 |
Why?
| | Gene Regulatory Networks | 7 | 2019 | 112 | 1.570 |
Why?
| | Evolution, Molecular | 10 | 2012 | 97 | 1.340 |
Why?
| | Transcriptome | 6 | 2021 | 367 | 1.230 |
Why?
| | Colonic Neoplasms | 3 | 2019 | 162 | 1.120 |
Why?
| | RNA | 4 | 2016 | 173 | 1.060 |
Why?
| | Sequence Analysis, RNA | 6 | 2019 | 96 | 0.850 |
Why?
| | Gene Expression | 6 | 2022 | 618 | 0.840 |
Why?
| | Proteome | 3 | 2021 | 177 | 0.830 |
Why?
| | Oligonucleotide Array Sequence Analysis | 10 | 2017 | 412 | 0.830 |
Why?
| | Systems Biology | 2 | 2011 | 33 | 0.670 |
Why?
| | Signal Transduction | 5 | 2019 | 1748 | 0.620 |
Why?
| | Genes, Neoplasm | 1 | 2019 | 31 | 0.610 |
Why?
| | Consensus | 1 | 2019 | 206 | 0.560 |
Why?
| | Software | 3 | 2017 | 280 | 0.550 |
Why?
| | Genes, p53 | 3 | 2013 | 51 | 0.540 |
Why?
| | Phylogeny | 8 | 2010 | 231 | 0.540 |
Why?
| | Colonic Polyps | 1 | 2017 | 39 | 0.530 |
Why?
| | High-Throughput Nucleotide Sequencing | 3 | 2015 | 180 | 0.530 |
Why?
| | Phenotype | 6 | 2025 | 803 | 0.520 |
Why?
| | Adenoma | 1 | 2017 | 114 | 0.490 |
Why?
| | Models, Genetic | 7 | 2008 | 169 | 0.490 |
Why?
| | Algorithms | 5 | 2025 | 667 | 0.490 |
Why?
| | Genes, X-Linked | 1 | 2014 | 7 | 0.450 |
Why?
| | Models, Statistical | 3 | 2012 | 229 | 0.370 |
Why?
| | Polycomb Repressive Complex 2 | 1 | 2012 | 48 | 0.370 |
Why?
| | Tumor Suppressor Protein p53 | 3 | 2017 | 228 | 0.360 |
Why?
| | Humans | 32 | 2025 | 53230 | 0.350 |
Why?
| | Disease | 1 | 2011 | 25 | 0.340 |
Why?
| | Genome, Viral | 3 | 2008 | 78 | 0.340 |
Why?
| | Azospirillum brasilense | 2 | 2022 | 4 | 0.340 |
Why?
| | Bacteriophages | 2 | 2007 | 10 | 0.330 |
Why?
| | Animals | 19 | 2021 | 13526 | 0.300 |
Why?
| | Principal Component Analysis | 2 | 2019 | 53 | 0.290 |
Why?
| | Computer Simulation | 4 | 2017 | 290 | 0.290 |
Why?
| | Genome | 2 | 2007 | 58 | 0.280 |
Why?
| | Proteomics | 3 | 2021 | 336 | 0.280 |
Why?
| | DNA | 3 | 2008 | 535 | 0.280 |
Why?
| | Genetic Variation | 3 | 2009 | 223 | 0.260 |
Why?
| | Biological Evolution | 2 | 2023 | 55 | 0.260 |
Why?
| | Base Sequence | 7 | 2013 | 620 | 0.250 |
Why?
| | Renal Insufficiency, Chronic | 2 | 2020 | 205 | 0.250 |
Why?
| | Chromosome Mapping | 2 | 2008 | 145 | 0.250 |
Why?
| | Gene Expression Regulation | 5 | 2017 | 1003 | 0.240 |
Why?
| | Molecular Sequence Data | 7 | 2012 | 759 | 0.240 |
Why?
| | Linkage Disequilibrium | 1 | 2005 | 41 | 0.240 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2025 | 92 | 0.230 |
Why?
| | Multivariate Analysis | 3 | 2017 | 598 | 0.220 |
Why?
| | Gene Expression Regulation, Neoplastic | 5 | 2021 | 868 | 0.220 |
Why?
| | Neoplasms | 2 | 2005 | 1334 | 0.220 |
Why?
| | Proteins | 2 | 2014 | 351 | 0.200 |
Why?
| | Nuclear Matrix | 1 | 2003 | 3 | 0.200 |
Why?
| | DNA, Intergenic | 1 | 2003 | 6 | 0.200 |
Why?
| | Primates | 1 | 2003 | 21 | 0.200 |
Why?
| | Conserved Sequence | 1 | 2003 | 55 | 0.190 |
Why?
| | Genomics | 3 | 2017 | 271 | 0.190 |
Why?
| | Cecum | 2 | 2021 | 62 | 0.190 |
Why?
| | Mutation | 4 | 2019 | 1337 | 0.190 |
Why?
| | Herbaspirillum | 1 | 2022 | 2 | 0.190 |
Why?
| | Binding Sites | 3 | 2012 | 373 | 0.180 |
Why?
| | Cell Cycle Proteins | 2 | 2017 | 170 | 0.180 |
Why?
| | Cluster Analysis | 2 | 2017 | 237 | 0.180 |
Why?
| | Cell Line, Tumor | 2 | 2017 | 1470 | 0.170 |
Why?
| | Selection, Genetic | 3 | 2012 | 27 | 0.160 |
Why?
| | Infant Formula | 1 | 2021 | 154 | 0.160 |
Why?
| | RNA, Untranslated | 1 | 2019 | 15 | 0.160 |
Why?
| | Sequence Alignment | 4 | 2007 | 119 | 0.150 |
Why?
| | Reproducibility of Results | 3 | 2016 | 1219 | 0.150 |
Why?
| | Gene Expression Regulation, Fungal | 2 | 2013 | 49 | 0.150 |
Why?
| | RNA, Messenger | 3 | 2019 | 1133 | 0.150 |
Why?
| | Ruminococcus | 1 | 2019 | 7 | 0.150 |
Why?
| | Starch | 1 | 2019 | 12 | 0.150 |
Why?
| | Extracellular Matrix | 1 | 2019 | 116 | 0.150 |
Why?
| | Phosphoproteins | 2 | 2013 | 117 | 0.140 |
Why?
| | Profilins | 1 | 2018 | 14 | 0.140 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 2018 | 33 | 0.140 |
Why?
| | Sample Size | 2 | 2015 | 50 | 0.140 |
Why?
| | Pharmacogenetics | 1 | 2018 | 52 | 0.140 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2017 | 33 | 0.140 |
Why?
| | Small Molecule Libraries | 1 | 2018 | 66 | 0.130 |
Why?
| | Hyperplasia | 1 | 2017 | 98 | 0.130 |
Why?
| | GTP-Binding Proteins | 1 | 2017 | 85 | 0.130 |
Why?
| | Chromatin | 2 | 2012 | 145 | 0.130 |
Why?
| | Neurodegenerative Diseases | 1 | 2018 | 81 | 0.130 |
Why?
| | Diet | 1 | 2021 | 610 | 0.130 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2017 | 136 | 0.130 |
Why?
| | DNA Replication | 2 | 2016 | 161 | 0.130 |
Why?
| | Lampreys | 2 | 2007 | 3 | 0.130 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2017 | 140 | 0.120 |
Why?
| | Data Mining | 1 | 2017 | 44 | 0.120 |
Why?
| | Down-Regulation | 1 | 2017 | 344 | 0.120 |
Why?
| | Protein Processing, Post-Translational | 1 | 2017 | 149 | 0.120 |
Why?
| | RNA-Binding Proteins | 1 | 2017 | 133 | 0.120 |
Why?
| | Protein Interaction Maps | 1 | 2016 | 28 | 0.120 |
Why?
| | Up-Regulation | 1 | 2017 | 456 | 0.120 |
Why?
| | Protein Interaction Mapping | 1 | 2016 | 38 | 0.120 |
Why?
| | Sequence Analysis, DNA | 2 | 2007 | 216 | 0.120 |
Why?
| | Models, Theoretical | 1 | 2017 | 180 | 0.120 |
Why?
| | Kidney | 1 | 2020 | 715 | 0.120 |
Why?
| | Mice | 5 | 2020 | 5982 | 0.120 |
Why?
| | Bacterial Proteins | 1 | 2019 | 347 | 0.120 |
Why?
| | Colorectal Neoplasms | 1 | 2019 | 302 | 0.120 |
Why?
| | Neoplasm Proteins | 1 | 2017 | 330 | 0.120 |
Why?
| | Breast Neoplasms | 3 | 2021 | 1222 | 0.110 |
Why?
| | Germ-Line Mutation | 2 | 2005 | 67 | 0.110 |
Why?
| | DNA Helicases | 1 | 2016 | 148 | 0.110 |
Why?
| | Data Interpretation, Statistical | 2 | 2013 | 169 | 0.100 |
Why?
| | Lymphocytes | 1 | 2014 | 146 | 0.100 |
Why?
| | Likelihood Functions | 2 | 2005 | 56 | 0.100 |
Why?
| | Nuclear Proteins | 2 | 2006 | 250 | 0.100 |
Why?
| | Lung Neoplasms | 1 | 2019 | 645 | 0.100 |
Why?
| | Activating Transcription Factor 1 | 1 | 2013 | 18 | 0.100 |
Why?
| | RNA, Fungal | 1 | 2013 | 18 | 0.100 |
Why?
| | RNA Stability | 1 | 2013 | 29 | 0.100 |
Why?
| | Schizosaccharomyces pombe Proteins | 1 | 2013 | 37 | 0.100 |
Why?
| | RNA, Antisense | 1 | 2012 | 6 | 0.100 |
Why?
| | Schizosaccharomyces | 1 | 2013 | 51 | 0.100 |
Why?
| | MAP Kinase Signaling System | 1 | 2013 | 127 | 0.100 |
Why?
| | Physical Chromosome Mapping | 1 | 2012 | 7 | 0.090 |
Why?
| | Amino Acid Sequence | 4 | 2008 | 563 | 0.090 |
Why?
| | RNA, Double-Stranded | 1 | 2012 | 23 | 0.090 |
Why?
| | Ribosomal Proteins | 1 | 2012 | 24 | 0.090 |
Why?
| | Tunica Intima | 1 | 2012 | 55 | 0.090 |
Why?
| | Carotid Arteries | 1 | 2012 | 77 | 0.090 |
Why?
| | Drosophila melanogaster | 1 | 2012 | 32 | 0.090 |
Why?
| | Rats | 3 | 2019 | 3162 | 0.090 |
Why?
| | Chromosome Disorders | 1 | 2012 | 32 | 0.090 |
Why?
| | Disease Progression | 3 | 2020 | 880 | 0.090 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2012 | 135 | 0.090 |
Why?
| | Adaptation, Physiological | 1 | 2012 | 109 | 0.090 |
Why?
| | Protein Array Analysis | 1 | 2010 | 24 | 0.080 |
Why?
| | Plant Roots | 2 | 2022 | 26 | 0.080 |
Why?
| | Gene Transfer, Horizontal | 2 | 2007 | 8 | 0.080 |
Why?
| | Ethanol | 1 | 2012 | 338 | 0.080 |
Why?
| | Bacteria | 2 | 2021 | 226 | 0.070 |
Why?
| | Flow Cytometry | 1 | 2010 | 400 | 0.070 |
Why?
| | Open Reading Frames | 2 | 2023 | 52 | 0.070 |
Why?
| | Periodicity | 1 | 2008 | 25 | 0.070 |
Why?
| | Chromosomes | 1 | 2008 | 28 | 0.070 |
Why?
| | Cell Proliferation | 1 | 2012 | 1031 | 0.070 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2008 | 61 | 0.070 |
Why?
| | Thermus thermophilus | 1 | 2008 | 1 | 0.070 |
Why?
| | Siphoviridae | 1 | 2008 | 1 | 0.070 |
Why?
| | Viral Proteins | 2 | 2008 | 164 | 0.070 |
Why?
| | Bayes Theorem | 2 | 2012 | 120 | 0.070 |
Why?
| | Male | 7 | 2020 | 27435 | 0.070 |
Why?
| | Cytosine Deaminase | 1 | 2007 | 8 | 0.070 |
Why?
| | DNA, Viral | 1 | 2008 | 136 | 0.070 |
Why?
| | Receptors, Antigen | 1 | 2007 | 2 | 0.070 |
Why?
| | Amino Acid Substitution | 2 | 2004 | 79 | 0.070 |
Why?
| | Aryldialkylphosphatase | 1 | 2007 | 6 | 0.070 |
Why?
| | Nuclear Envelope | 1 | 2006 | 4 | 0.060 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2007 | 83 | 0.060 |
Why?
| | Adaptation, Biological | 1 | 2005 | 10 | 0.060 |
Why?
| | Receptors, Immunologic | 1 | 2005 | 36 | 0.060 |
Why?
| | Immunity | 1 | 2005 | 35 | 0.060 |
Why?
| | Saccharomyces cerevisiae | 1 | 2006 | 166 | 0.060 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2006 | 131 | 0.060 |
Why?
| | Pan troglodytes | 1 | 2005 | 10 | 0.060 |
Why?
| | Fossils | 1 | 2005 | 19 | 0.060 |
Why?
| | Hominidae | 1 | 2005 | 18 | 0.060 |
Why?
| | Nucleic Acid Hybridization | 1 | 2005 | 53 | 0.060 |
Why?
| | Calibration | 1 | 2005 | 58 | 0.060 |
Why?
| | DNA, Neoplasm | 1 | 2005 | 146 | 0.060 |
Why?
| | Mutation, Missense | 1 | 2005 | 110 | 0.050 |
Why?
| | Species Specificity | 1 | 2005 | 191 | 0.050 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2011 | 591 | 0.050 |
Why?
| | Genes, Archaeal | 1 | 2004 | 1 | 0.050 |
Why?
| | Gene Expression Regulation, Archaeal | 1 | 2004 | 1 | 0.050 |
Why?
| | Chickens | 1 | 2005 | 106 | 0.050 |
Why?
| | Genes | 1 | 2004 | 30 | 0.050 |
Why?
| | Genes, Fungal | 1 | 2004 | 23 | 0.050 |
Why?
| | Disease Models, Animal | 2 | 2020 | 1517 | 0.050 |
Why?
| | Genes, Bacterial | 1 | 2004 | 51 | 0.050 |
Why?
| | Genes, Tumor Suppressor | 1 | 2004 | 73 | 0.050 |
Why?
| | Eukaryotic Cells | 1 | 2004 | 15 | 0.050 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2007 | 505 | 0.050 |
Why?
| | Inheritance Patterns | 1 | 2004 | 22 | 0.050 |
Why?
| | Statistics as Topic | 1 | 2004 | 89 | 0.050 |
Why?
| | CpG Islands | 1 | 2004 | 114 | 0.050 |
Why?
| | Membrane Proteins | 1 | 2006 | 333 | 0.050 |
Why?
| | Quality Control | 1 | 2004 | 98 | 0.050 |
Why?
| | Genome, Bacterial | 1 | 2004 | 60 | 0.050 |
Why?
| | Tumor Suppressor Proteins | 1 | 2004 | 130 | 0.050 |
Why?
| | Nucleotides | 1 | 2023 | 22 | 0.050 |
Why?
| | Trans-Activators | 1 | 2004 | 139 | 0.050 |
Why?
| | DNA Topoisomerases, Type I | 1 | 2003 | 3 | 0.050 |
Why?
| | DNA Topoisomerases, Type II | 1 | 2003 | 16 | 0.050 |
Why?
| | Time | 1 | 2003 | 28 | 0.050 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2003 | 46 | 0.050 |
Why?
| | Myocardial Infarction | 1 | 2007 | 445 | 0.050 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2004 | 177 | 0.050 |
Why?
| | DNA Transposable Elements | 1 | 2003 | 107 | 0.050 |
Why?
| | Immunoglobulins | 1 | 2003 | 76 | 0.050 |
Why?
| | Female | 4 | 2021 | 28782 | 0.040 |
Why?
| | DNA-Binding Proteins | 1 | 2004 | 423 | 0.040 |
Why?
| | Transcription Factors | 1 | 2004 | 571 | 0.040 |
Why?
| | Models, Animal | 1 | 2021 | 233 | 0.040 |
Why?
| | Blood Urea Nitrogen | 1 | 2020 | 40 | 0.040 |
Why?
| | Nucleic Acid Conformation | 2 | 2013 | 82 | 0.040 |
Why?
| | Animals, Newborn | 1 | 2021 | 357 | 0.040 |
Why?
| | Swine | 1 | 2021 | 440 | 0.040 |
Why?
| | Milk, Human | 1 | 2021 | 122 | 0.040 |
Why?
| | Decision Trees | 1 | 2019 | 23 | 0.040 |
Why?
| | RNA, Plant | 1 | 2019 | 6 | 0.040 |
Why?
| | Genes, Plant | 1 | 2019 | 11 | 0.040 |
Why?
| | Symbiosis | 1 | 2019 | 12 | 0.040 |
Why?
| | Gene Expression Regulation, Plant | 1 | 2019 | 50 | 0.040 |
Why?
| | Cell Cycle | 2 | 2012 | 237 | 0.040 |
Why?
| | Motor Neurons | 1 | 2018 | 35 | 0.040 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2019 | 147 | 0.040 |
Why?
| | Neuroglia | 1 | 2018 | 39 | 0.040 |
Why?
| | Time Factors | 1 | 2005 | 2991 | 0.040 |
Why?
| | Spinal Cord | 1 | 2018 | 130 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2017 | 124 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2018 | 561 | 0.030 |
Why?
| | Models, Biological | 1 | 2019 | 737 | 0.030 |
Why?
| | Phosphorylation | 1 | 2017 | 533 | 0.030 |
Why?
| | MicroRNAs | 1 | 2019 | 397 | 0.030 |
Why?
| | Prognosis | 1 | 2021 | 2118 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 1 | 2019 | 1544 | 0.030 |
Why?
| | Cell Line | 1 | 2017 | 1016 | 0.030 |
Why?
| | Databases, Factual | 1 | 2018 | 742 | 0.030 |
Why?
| | DNA Repair | 1 | 2016 | 197 | 0.030 |
Why?
| | Research Design | 1 | 2016 | 373 | 0.030 |
Why?
| | G1 Phase | 1 | 2012 | 13 | 0.020 |
Why?
| | Tunica Media | 1 | 2012 | 11 | 0.020 |
Why?
| | S Phase | 1 | 2012 | 20 | 0.020 |
Why?
| | Mice, Inbred C3H | 1 | 2012 | 81 | 0.020 |
Why?
| | Lod Score | 1 | 2012 | 7 | 0.020 |
Why?
| | Microarray Analysis | 1 | 2012 | 69 | 0.020 |
Why?
| | Genes, Insect | 1 | 2012 | 11 | 0.020 |
Why?
| | Molecular Sequence Annotation | 1 | 2012 | 28 | 0.020 |
Why?
| | Larva | 1 | 2012 | 32 | 0.020 |
Why?
| | Mice, Inbred Strains | 1 | 2012 | 163 | 0.020 |
Why?
| | Genetic Association Studies | 1 | 2012 | 124 | 0.020 |
Why?
| | Internet | 1 | 2012 | 265 | 0.020 |
Why?
| | Prostatic Neoplasms | 1 | 2013 | 401 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2012 | 1569 | 0.020 |
Why?
| | Virion | 1 | 2008 | 18 | 0.020 |
Why?
| | Breast | 1 | 2008 | 87 | 0.020 |
Why?
| | DNA, Complementary | 1 | 2008 | 128 | 0.020 |
Why?
| | Glioma | 1 | 2008 | 83 | 0.020 |
Why?
| | Recombination, Genetic | 1 | 2008 | 95 | 0.020 |
Why?
| | Aspartic Acid | 1 | 2007 | 45 | 0.020 |
Why?
| | Age of Onset | 1 | 2007 | 109 | 0.020 |
Why?
| | Chromosome Segregation | 1 | 2006 | 11 | 0.020 |
Why?
| | Centrosome | 1 | 2006 | 11 | 0.020 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2006 | 135 | 0.020 |
Why?
| | Glutamic Acid | 1 | 2007 | 105 | 0.020 |
Why?
| | Bacillus subtilis | 1 | 2005 | 5 | 0.020 |
Why?
| | Spores, Bacterial | 1 | 2005 | 6 | 0.020 |
Why?
| | Bacillus anthracis | 1 | 2005 | 14 | 0.010 |
Why?
| | Protein Structure, Tertiary | 1 | 2006 | 252 | 0.010 |
Why?
| | Glutamine | 1 | 2007 | 177 | 0.010 |
Why?
| | Arginine | 1 | 2007 | 178 | 0.010 |
Why?
| | Genotype | 1 | 2007 | 563 | 0.010 |
Why?
| | Gene Rearrangement | 1 | 2005 | 76 | 0.010 |
Why?
| | Brain Neoplasms | 1 | 2008 | 319 | 0.010 |
Why?
| | Protein Binding | 1 | 2006 | 670 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2007 | 533 | 0.010 |
Why?
| | Locus Control Region | 1 | 2003 | 1 | 0.010 |
Why?
| | Globins | 1 | 2003 | 12 | 0.010 |
Why?
| | Terminal Repeat Sequences | 1 | 2003 | 10 | 0.010 |
Why?
| | 5' Untranslated Regions | 1 | 2003 | 29 | 0.010 |
Why?
| | Repetitive Sequences, Nucleic Acid | 1 | 2003 | 86 | 0.010 |
Why?
| | False Positive Reactions | 1 | 2002 | 66 | 0.010 |
Why?
| | Mammals | 1 | 2002 | 58 | 0.010 |
Why?
| | Plants | 1 | 2002 | 29 | 0.010 |
Why?
| | Cohort Studies | 1 | 2007 | 1557 | 0.010 |
Why?
| | Genome, Human | 1 | 2003 | 121 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2007 | 2318 | 0.010 |
Why?
| | Prospective Studies | 1 | 2007 | 2411 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2003 | 465 | 0.010 |
Why?
| | Brain | 1 | 2008 | 1350 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2007 | 3494 | 0.010 |
Why?
| | Risk Factors | 1 | 2007 | 4017 | 0.010 |
Why?
| | Aged | 1 | 2007 | 10429 | 0.010 |
Why?
| | Middle Aged | 1 | 2007 | 13419 | 0.010 |
Why?
| | Adult | 1 | 2007 | 14534 | 0.010 |
Why?
|
|
Glazko's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|